Damodhar Suresh, MD
Interventional Cardiology · Edgewood, KYNPI 1356348346
Payments from drug & device makers
Across 542 payments — averaging $55.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$14K
- Novartis$5K
- Medtronic$2K
- Abbott$2K
- Amgen$2K
- Abiomed$973
- plus $6K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 55 | $13,737 |
| Novartis | 96 | $4,800 |
| Medtronic(2 entities) | 11 | $1,915 |
| Abbott | 22 | $1,692 |
| Amgen | 81 | $1,576 |
| Abiomed | 12 | $973 |
| Johnson & Johnson | 67 | $882 |
| Bayer | 24 | $880 |
| Boehringer Ingelheim | 28 | $554 |
| Pfizer | 25 | $387 |
| Boston Scientific | 9 | $371 |
| Amarin Pharma, Inc. | 24 | $320 |
| E.r. Squibb & Sons, L.L.C. | 12 | $211 |
| Inari Medical, Inc. | 1 | $198 |
| Edwards Lifesciences | 1 | $193 |
| Merck | 10 | $189 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $170 |
| Heartflow, Inc. | 1 | $167 |
| Penumbra, Inc. | 1 | $152 |
| Regeneron Healthcare Solutions, Inc. | 14 | $141 |
| Novo Nordisk | 7 | $126 |
| GSK | 1 | $120 |
| Getinge USA Sales, LLC | 2 | $120 |
| Esperion Therapeutics, Inc. | 7 | $115 |
| GE HealthCare | 1 | $80 |
| Chiesi USA, Inc. | 4 | $54 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 2 | $30 |
| Scpharmaceuticals Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Verge Medical, Inc. | 1 | $12 |
How this compares
$30,318 in reported general payments places this provider in the 70th percentile of 129 interventional cardiology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Edgewood
- Amit SrivastavaEdgewood$736K
- Mohanjit BrarEdgewood$216K
- Abiodun IsholaEdgewood$52K
- Saeb KhouryEdgewood$17K
- Thomas TuLouisville$1.4M
- Avichai EresLexington$616K
- Naresh SolankhiLouisville$545K
- Sreedevi GondiLouisville$535K
- Steve LinLexington$372K
- Daniel StewartLouisville$290K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.